The impact of COPD on the private healthcare system in Brazil: an economic analysis / Impacto da DPOC no sistema de saúde privado no Brasil: uma análise econômica
Nascimento, Oliver Augusto; Saturnino, Luciana Tarbes Mattana; Santos, Felipe Moares dos; Silva, Danielle Oliveira da; Gazzotti, Mariana Rodrigues; Martins, Franco Chies; Gomes, Ana Luisa Bessa Bacellar; Viana, Karynna Pimentel; Afonso-Cristancho, Rafael; Rodrigues, Claudia Soares.
J. bras. econ. saúde (Impr.)
; 15(1): 59-66, Abril/2023.
Artículo
en Inglés, Portugués
| LILACS, ECOS | ID: biblio-1437952
Objective:
To assess healthcare resource utilization and hospitalization costs of patients with chronic obstructive pulmonary disease (COPD) exacerbations in the Brazilian private healthcare system.Methods:
A retrospective cohort study, considering data from an administrative database of a private company (Orizon). Patients aged ≥40 years old and with at least one COPD-related claim identified by the ICD-10 code (J40 to J44) at any time during the eligibility period (January/2010 to December/2013) were included in the analysis. Follow-up was performed until December/2014, death or inactivation of a health plan. Sociodemographic characteristics, number of emergency visits, hospital admissions (number and length of stay), length of hospital stay in an intensive care unit (ICU), number of severe COPD exacerbations, therapeutic approach, and hospitalization costs were assessed.Results:
The analysis included 8,254 COPD patients. Emergency visits, hospital admission, and exacerbation rates were 0.4, 0.2, and 0.1 per person-year, respectively. The mean length of hospital stays and the length of stay of patients requiring or not ICU stay were 16.6 (SD = 77.0), 8.7 (SD = 36.9), and 27.6 (SD = 109.7), respectively. Mean costs associated to emergency department visits and hospitalizations were 258.2 BRL (SD = 383.1) and 38,165.4 BRL (SD = 124,683.5), respectively. Hospitalizations costs without ICU stay were 11,810.1 BRL (SD = 31,144.1) and 74,585.3 BRL (SD = 182,808.1) for those with ICU utilization.Conclusion:
Costs for COPD management during disease exacerbation are very high and may reach almost 75 thousand BRL per hospitalization. The prevention of COPD exacerbations and better disease control may reduce the economic burden on the private healthcare system in Brazil.
Biblioteca responsable:
BR600
Ubicación: BR600
Texto completo
Documentos relacionados